While cosmetic enhancements, such as fillers and Botox, will still be (unfortunately) considered taboo in today’s society, surprisingly, the number of people getting work done is headed up and up. In fact, in 2015, Americans were injected greater than 6.6 million times, in accordance with the American Society for Aesthetic Plastic Surgery, that is a whopping 40 percent increase from five years ago. And today, those 6 million and counting have yet another option to consider when booking their next appointment, as the FDA just approved a brandname-new filler: Juvéderm Vollure XC.
Allergan, the pharmaceutical company that owns Juvéderm, just announced its newest juvederm los angeles, Juvéderm Vollure XC, which was approved for that correction of “moderate to severe facial wrinkles and folds, such as nasolabial folds,” as outlined by an announcement manufactured by the business. What’s more is that this filler, manufactured for those over 21, is considered to last given that 18 months – a complete year longer than other injectables available on the market.
In a clinical trial for the injectable, 59 percent of participants saw improvement in smile lines round the mouth for approximately 18 months, and as well, 82 percent of patients said these folks were content with results at 6 months, while 68 percent were still pleased at eight months. Sounds great, but just how can it work? We tapped The Big Apple dermatologist Joshua Zeichner to get more about the technology behind the filler.
Juvéderm Vollure XC uses special technology, referred to as Vycross – that is also utilized in Juvéderm Voluma XC and Juvéderm Volbella XC – to keep the hyaluronic acid together into a cohesive gel, which will keep it intact after it’s injected into the skin, explains Zeichner. “Vollure XC’s Vycross technology links both high and low molecular-weight hyaluronic acid, while Juvederm’s Hylacross technology uses various levels of cross-linking of mainly high molecular weight hyaluronic acid.”
In non-cosmetic surgeon speak, that means that the mixture of high and low hyaluronic acid within the Vycross technology produces a more connected gel, which is often molded, effectively lifting sunken skin sitting above it. “Vollure sits because sweet spot where it is actually firm enough to fill the fishing line, but soft enough to move naturally with facial expression,” says Zeichner. Another major difference between Juvéderm and also the new Juvéderm Vollure XC is the new formula produces minimal swelling, which suggests shorter time to recover. “The gel also may keep going longer than other products, rendering it a greater value for the price and the requirement for fewer injection sessions,” says Zeichner.